During the past decade, Sakai Municipal Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sakai Municipal Hospital" #1 sponsor was "Haruhiko Fukuda" with 4 trials, followed by "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 3 trials sponsored, "Japan Clinical Cancer Research Organization" with 2 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Janssen Pharmaceutical K.K." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sakai Municipal Hospital" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 4 trials as a collaborator, "Niigata University Medical & Dental Hospital" with 2 trials as a collaborator, "Japan Breast Cancer Research Group (JBCRG)" with 1 trials as a collaborator, "Korean Cancer Study Group" with 1 trials as a collaborator and "Korean Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Sakai Municipal Hospital" are "Gastric Cancer" (2 trials), "Gastric Neoplasm" (2 trials), "Gastrointestinal Stromal Tumor" (2 trials), "Metastatic Cancer" (2 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Sakai Municipal Hospital" in a lesser frequency.

Most popular intervention types in "Sakai Municipal Hospital" are "Drug" (10 trials), "Procedure" (4 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "5FU+l-leucovorin" (1 trials), "Archival Tumor Tissue Sample" (1 trials), "Gastrectomy with more than D2 dissection" (1 trials) and "Mesorectal excision with lateral lymph node dissection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sakai Municipal Hospital" are 13 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Sakai Municipal Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Sakai Municipal Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sakai Municipal Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".